The therapeutic potential of modulators of the Hedgehog-Gli signaling pathway

Frank-Kamenetsky M, Zhang XM, Bottega S, Guicherit O, Wichterle H, Dudek H, Bumcrot D, Wang FY, Jones S, Shulok J, Rubin LL, Porter JA: Small molecule modulators of hedgehog signaling: identification and characterization of smoothened agonists and antagonists. J Biol. 2002, 1: 10-10.1186/1475-4924-1-10. Ho KS, Scott MP: Sonic hedgehog in the nervous system: functions, modifications and mechanisms. Curr Opin Neurobiol. 2002, 12: 57-63. 10.1016/S0959-4388(02)00290-8. Nybakken K, Perrimon N: Hedgehog signal transduction: recent findings. Curr Opin Genet Dev. 2002, 12: 503-511. 10.1016/S0959-437X(02)00333-7. Ruiz i Altaba A, Palma V, Dahmane N: Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci. 2002, 3: 24-33. 10.1038/nrn704. Mullor J, Sanchez P, Ruiz i Altaba A: Pathways and consequences: Hedgehog signaling in human diseases. Trends Cell Biol. Roessler E, Belloni E, Gaudenz K, Jay P, Berta P, Scherer SW, Tsui LC, Muenke M: Mutations in the human sonic hedgehog gene cause holoprosencephaly. Nat Genet. 1996, 14: 357-360. Ming JE, Kaupas ME, Roessler E, Brunner HG, Golabi M, Tekin M, Stratton RF, Sujansky E, Bale SJ, Muenke M: Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly. Hum Genet. 2002, 110: 297-301. 10.1007/s00439-002-0695-5. Muenke M, Beachy PA: Holoprosencephaly. In Metabolic and Molecular Bases of Inherited Disease. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Hilds B, Kinzler KW, Vogelstein B. 2001, New York: McGraw-Hill, 6203-6230. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein EH, Scott MP: Basal cell carcinomas in mice overexpressing sonic hedgehog. Science. 1997, 276: 817-821. 10.1126/science.276.5313.817. Dahmane N, Lee J, Robin P, Heller P, Ruiz i Altaba : Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature. 1997, 389: 876-881. 10.1038/39918. Nilsson M, Unden AB, Krause D, Malmqwist U, Raza K, Zaphiropoulos PG, Toftgard R: Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci USA. 2000, 97: 3438-3443. 10.1073/pnas.050467397. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, Hui C-c, Dlugosz AA: Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet. 2000, 24: 216-217. 10.1038/73417. Ruiz i Altaba A, Sanchez P, Dahmane N: Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer. 2002, 2: 361-372. 10.1038/nrc796. Taylor MD, Liu L, Raffel C, Hui C-c, Mainproze TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, et al: Mutations in SUFU predispose to medulloblastoma. Nat Genet. 2002, 31: 306-310. 10.1038/ng916. Goodrich LV, Milenkovic L, Higgins KM, Scott MP: Altered neural cell fates and medulloblastoma in mouse patched mutants. Science. 1997, 277: 1109-1113. 10.1126/science.277.5329.1109. Raffel C, Jenkins RB, Frederick l, Hebrink D, Alderete B, Fults DW, James CD: Sporadic medulloblastomas contains PTCH mutations. Cancer Res. 1997, 57: 842-845. Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G: Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 1997, 57: 2581-2585. Dahmane N, Sanchez P, Gitton Y, Palma V, Sun T, Beyna M, Weiner H, Ruiz i Altaba A: The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development. 2001, 128: 5201-5212. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, et al: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002, 415: 436-442. 10.1038/415436a. Tsuboi K, Shults CW: Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease. Exp Neurol. 2002, 173: 95-104. 10.1006/exnr.2001.7825. Wang MZ, Jin P, Bumcrot DA, Marigo V, McMahon AP, Wang EA, Woolf T, Pang K: Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein. Nat Med. 1995, 1: 1184-1188. Hynes M, Porter JA, Chiang C, Chang D, Tessier-Lavigne M, Beachy PA: Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron. 1995, 15: 35-44. Miao N, Wang M, Ott JA, D'Alessandro JS, Woolf TM, Bumcrot DA, Mahanthappa NK, Pang K: Sonic hedgehog promotes the survival of specific CNS neuron populations and protects these cells from toxic insult in vitro. J Neurosci. 1997, 17: 5891-5899. Pepinsky RB, Shapiro RI, Wang S, Chakraborty A, Gill A, Lepage D, Wen D, Rayhorn , Horan GSB, Taylor FR, et al: Long-acting form of sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury model. J Pharm Sci. 2002, 91: 371-387. 10.1002/jps.10052. Chen JK, Taipale J, Young KE, Maiti T, Beachy PA: Small molecule modulation of Smoothened activity. Proc Natl Acad Sci USA. 2002, 99: 14071-14076. 10.1073/pnas.182542899. Ericson J, Morton S, Kawakami A, Roelink H, Jessel TM: Two critical periods of sonic hedgehog signaling required for the specification of motor neuron identity. Cell. 1996, 87: 661-673. Incardona JP, Gaffield W, Kapur RP, Roelink H: The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development. 1998, 125: 3553-3562. Cooper MK, Porter JA, Young KE, Beachy PA: Teratogen-mediated inhibition of target tissue response to Shh signaling. Science. 1998, 280: 1603-1607. 10.1126/science.280.5369.1603. Taipale J, Chen JK, Cooper MK, Wang B, Mann RK, Milenkovic L, Scott MP, Beachy PA: Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature. 2000, 406: 1005-1009. 10.1038/35023008. Fan CM, Porter JA, Chiang C, Chang DT, Beachy PA, Tessier-Lavigne M: Long-range sclerotome induction by sonic hedgehog: direct role of the amino-terminal cleavage product and modulation by the cyclic AMP signaling pathway. Cell. 1995, 81: 457-465. Ruiz i Altaba : Gli proteins encode context-dependent positive and negative functions: implication for development and diseases. Development. 1999, 126: 3205-3216. Berman DM, Karhadkar SS, Hallahan AR, Pritchard JI, Eberhart CG, Watkins DN, Chen JK, Cooper MK, Taiplae J, Olson JM, Beachy PA: Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 2002, 297: 1559-1561. 10.1126/science.1073733. Williams JA, Guicherit OM, Zaharian BI, Xu Y, Chai L, Gatchalian C, Porter JA, Rubin LL, Wang FY: Identification of novel inhibitors of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci USA. 2002, Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H: Regulation of Gli2 and Gli3 activities by an amino-terminal repressor domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development. 1999, 126: 3915-3924. Shin SH, Kogerman P, Lindstrom E, Toftgard R, Biesecker LG: Gli3 mutations in human disorders mimic Drosophila cubitus interruptus protein functions and localizations. Proc Natl Acad Sci USA. 1999, 96: 2880-2884. 10.1073/pnas.96.6.2880. Derossi D, Chassing G, Prochiantz A: Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 1998, 8: 84-87. 10.1016/S0962-8924(97)01214-2.